EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery

Victor Uchenna Chigozie, Kennedy Izuchukwu Ogunwa, Nkeiruka Grace Osuafor, Leslie Luxe Nduwimana, Daniel Ikechukwu Oraekei

Applied Microbiology and Biotechnology · 03.08.2026 · 110 (1)

DOI: 10.1007/s00253-026-13975-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 03.08.2026. Verfasst von Victor Uchenna Chigozie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology and Biotechnology, David Umahi Federal University of Health Sciences, Ebonyi, Uburu, Nigeria. chigozievu@du…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Fungi, Drug Discovery. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine kinase inhibitors (TKIs) remain a major focus of targeted therapeutic discovery, yet current discovery pipelines are constrained by resistance development, limited scaffold diversity, and high attrition rates. Entomopathogenic fungi (EPF) represent an underexplored microbial resource with significant biosynthetic potential for generating kinase-relevant secondary metabolites. Recent genomic studies reveal that EPF encode diverse and largely cryptic biosynthetic gene clusters (BGCs), including polyketide synthase (PKS), non-ribosomal peptide synthetase (NRPS), and hybrid pathways capable of producing structurally complex bioactive compounds. This mini-review examines the biotechnological exploitation of EPF for TKI discovery, focusing on fungal metabolites with direct or indirect kinase-related activity, genome mining strategies, biosynthetic logic, pathway regulation, and engineering approaches for metabolite production. Although only a limited number of EPF-derived metabolites have been experimentally validated as direct tyrosine kinase inhibitors, accumulating evidence indicates that many modulate kinase-associated signalling pathways and represent promising starting points for kinase-oriented natural product discovery. Particular emphasis is placed on pathway activation, heterologous expression, metabolic engineering, and scalable bioprocess development. Key translational challenges, including selectivity, toxicity, yield instability, and regulatory considerations, are also discussed. Collectively, this review highlights EPF as promising microbial platforms for kinase-oriented natural product discovery and provides a biotechnology-focused framework for advancing fungal secondary metabolites toward translational development. Key points • Entomopathogenic fungi encode diverse kinase-active secondary metabolites. • Genome mining and synthetic biology unlock cryptic TKI pathways. • Biotechnological optimization is critical for scalable fungal TKI discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsFungiDrug DiscoveryMetabolic EngineeringBiosynthetic PathwaysMultigene FamilyBiological ProductsTyrosine Kinase InhibitorsAnimalsInsectaPeptide SynthasesProtein-Tyrosine Kinases

Stichwörter der Autor:innen

Biosynthetic gene clustersEntomopathogenic fungiMetabolic engineeringNatural product drug discoverSecondary metabolismTyrosine kinase inhibitors

Substanzen

Protein Kinase InhibitorsBiological ProductsTyrosine Kinase InhibitorsPeptide SynthasesProtein-Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Pharmaceutical Microbiology and Biotechnology, David Umahi Federal University of Health Sciences, Ebonyi, Uburu, Nigeria. chigozievu@dufuhs.edu.ng.
  • NaPBiTReG (Natural Products Bioprospecting and Translation Research Group), International Institute for Pharmaceutical Research and Innovation (IIPRI), Uburu, Ebonyi, Nigeria. chigozievu@dufuhs.edu.ng.
  • Department of Pharmaceutical Microbiology and Biotechnology, Olivia University, Mukaza, Bujumbura, Burundi. chigozievu@dufuhs.edu.ng.
  • Department of Industrial and Medicinal Chemistry, David Umahi Federal University of Health Sciences, Uburu, Nigeria.
  • International Institute for Toxicology, Environmental & Occupational Health and Safety Research, DUFUHS, Ebonyi, Nigeria.
  • Department of Clinical Pharmacy and Pharmacy Administration, University of Abuja, FCT, Abuja, Nigeria.

Zitieren

APA

Chigozie, V. U., Ogunwa, K. I., Osuafor, N. G., Nduwimana, L. L., & Oraekei, D. I. (2026). Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery. Applied Microbiology and Biotechnology, 110(1). https://doi.org/10.1007/s00253-026-13975-y

Vancouver

Chigozie VU, Ogunwa KI, Osuafor NG, Nduwimana LL, Oraekei DI. Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery. Applied Microbiology and Biotechnology. 2026;110(1). doi:10.1007/s00253-026-13975-y

BibTeX
@article{Chigozie2026,
  author = {Chigozie, Victor Uchenna and Ogunwa, Kennedy Izuchukwu and Osuafor, Nkeiruka Grace and Nduwimana, Leslie Luxe and Oraekei, Daniel Ikechukwu},
  title = {Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery},
  journal = {Applied Microbiology and Biotechnology},
  year = {2026},
  volume = {110},
  number = {1},
  doi = {10.1007/s00253-026-13975-y}
}
Kostenlos starten →